Literature DB >> 19524254

Clinical characterization of pediatric pulmonary hypertension: complex presentation and diagnosis.

Rosa Laura E van Loon1, Marcus T R Roofthooft, Magdalena van Osch-Gevers, Tammo Delhaas, Jan L M Strengers, Nico A Blom, Ad Backx, Rolf M F Berger.   

Abstract

OBJECTIVES: To describe the clinical presentation of pediatric pulmonary arterial hypertension (PAH) and the intricacies of how to classify pediatric PAH according to the Venice classification. STUDY
DESIGN: Children (n = 63) seen at a national referral center for pediatric PAH underwent a diagnostic work-up for diagnosis of pulmonary hypertension (PH) and associated conditions and for assessment of the explanatory role of associated conditions for the PH. Subsequently, PH was classified.
RESULTS: In 18 patients (29%), no associated conditions were identified; they were classified as having idiopathic PAH. In 45 patients (71%), > or = 1 associated conditions were detected: congenital heart defects (CHD, n = 40), connective tissue disease (CTD, n = 2), disorders of respiratory system and/or hypoxemia (RSH, n = 17), and chronic thromboembolic disease (CTE, n = 1). Patients were classified according to the condition judged to be primarily explanatory for the PH. In 11 of 45 patients with associated conditions, the PH was not sufficiently explained by these conditions; these patients were classified as having idiopathic-like PAH. In 17 of 40 cases of CHD and 9 of 17 cases of RSH, these conditions were not sufficiently explanatory for the PH. Syndromal abnormalities were frequent (43%). Ultimately, classification revealed idiopathic (-like) PAH (n = 29; 46%), PAH-CHD (n = 23; 37%), PAH-CTD (n = 2; 3%), PH-RSH (n = 8; 12%), and CTE-PH (n = 1; 2%).
CONCLUSION: Pediatric PH frequently presents with associated conditions and syndromal abnormalities. However, detailed evaluation of this complex presentation reveals that associated conditions are not always explanatory for the PH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19524254     DOI: 10.1016/j.jpeds.2009.02.036

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  21 in total

Review 1.  Advances in pediatric pulmonary arterial hypertension.

Authors:  Dunbar Ivy
Journal:  Curr Opin Cardiol       Date:  2012-03       Impact factor: 2.161

Review 2.  Pulmonary arterial hypertension: a comparison between children and adults.

Authors:  R J Barst; S I Ertel; M Beghetti; D D Ivy
Journal:  Eur Respir J       Date:  2011-03       Impact factor: 16.671

Review 3.  Recent progress in understanding pediatric pulmonary hypertension.

Authors:  Steven H Abman; D Dunbar Ivy
Journal:  Curr Opin Pediatr       Date:  2011-06       Impact factor: 2.856

4.  Clinical features of paediatric pulmonary hypertension: a registry study.

Authors:  Rolf M F Berger; Maurice Beghetti; Tilman Humpl; Gary E Raskob; D Dunbar Ivy; Zhi-Cheng Jing; Damien Bonnet; Ingram Schulze-Neick; Robyn J Barst
Journal:  Lancet       Date:  2012-01-11       Impact factor: 79.321

5.  Serum Pentraxin 3 and hs-CRP Levels in Children with Severe Pulmonary Hypertension.

Authors:  Cemşit Karakurt; Osman Başpınar; Fazlı Serkan Çelik; Çağatay Taşkapan; Aydın Derya Şahin; Saim Yoloğlu
Journal:  Balkan Med J       Date:  2014-09-01       Impact factor: 2.021

6.  Prevalence of Pulmonary Hypertension in Pediatric Patients With Obstructive Sleep Apnea and a Cardiology Evaluation: A Retrospective Analysis.

Authors:  Antoinette T Burns; Shana L Hansen; Zachary S Turner; James K Aden; Alexander B Black; Daniel P Hsu
Journal:  J Clin Sleep Med       Date:  2019-08-15       Impact factor: 4.062

7.  Comparison of the therapeutic and side effects of tadalafil and sildenafil in children and adolescents with pulmonary arterial hypertension.

Authors:  Mohammad Reza Sabri; Elham Beheshtian
Journal:  Pediatr Cardiol       Date:  2013-11-20       Impact factor: 1.655

8.  Medical therapy for pediatric pulmonary arterial hypertension.

Authors:  Cecile Tissot; David Dunbar Ivy; Maurice Beghetti
Journal:  J Pediatr       Date:  2010-07-24       Impact factor: 4.406

9.  Clinical classification in pediatric pulmonary arterial hypertension associated with congenital heart disease.

Authors:  Willemijn M H Zijlstra; Johannes M Douwes; Mark-Jan Ploegstra; Usha Krishnan; Marcus T R Roofthooft; Hans L Hillege; D Dunbar Ivy; Erika B Rosenzweig; Rolf M F Berger
Journal:  Pulm Circ       Date:  2016-09       Impact factor: 3.017

Review 10.  Management of Pulmonary Arterial Hypertension in the Pediatric Patient.

Authors:  Jordan E Ezekian; Kevin D Hill
Journal:  Curr Cardiol Rep       Date:  2019-11-28       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.